Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMD3100 with G-CSF and Rituximab for Stem Cell Mobilization
NCT00444912Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Sanofi. Started Feb 2006; status: completed.
02
Drugs
plerixafor
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00444912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444912.